Pure Global AI
NCT05843461Recruiting

PIMR and Pulmonary Vascular Disease

The Pulmonary Index of Microcirculatory Resistance: A Novel Hemodynamic Index for Invasively Assessing the Pulmonary Vasculature
University of California, Los AngelesClinicalTrials.govother
Study focus
Disease/Condition
Pulmonary Hypertension
Drug/Device/Intervention
Pulmonary Index of Microcirculatory Resistance
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
University of California, Los Angeles
Location
Los Angeles, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 10, 2023
End date
Apr 30, 2024
Enrollment
30 participants
Primary outcome

Pulmonary Index of Microcirculatory Resistance (PIMR),Right Ventricle Index of Microcirculatory Resistance (RV-IMR),OCT-derived pulmonary artery wall thickness,OCT-derived thickness-diameter ratio,OCT-derived wall-area ratio

Summary

The findings from this innovative, first-in-man, prospective pilot study will elucidate the
 role of PIMR and RV-IMR in pre-capillary PH. The study cohort will consist of patients with
 pulmonary pressures ranging from normal (advanced lung disease patients undergoing lung
 transplant evaluation) to severe PH (PAH and CTEPH patients), and thus will allow for
 identification of a PIMR cutoff. Participants will include: 1) advanced lung disease patients
 undergoing bilateral heart catheterization as part of their pre-lung transplant work-up, and
 2) newly referred patients to PAH and CTEPH clinics undergoing bilateral heart
 catheterization as part of standard of care work-up. All participants will undergo PIMR
 testing, and those with pre-capillary PH will also undergo pulmonary OCT and measurement of
 RV-IMR. The study seeks to define the relationship between PIMR and PH and to establish the
 PIMR threshold that identifies pulmonary microvascular dysfunction as well as to evaluate the
 association of PIMR and pulmonary vascular remodeling on OCT in patients with pre-capillary
 PH. In addition, the study will assess the relationship between RV-IMR and RV pressure
 overload among patients with pre-capillary PH.

ICD-10 classifications
Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationPulmonary heart disease, unspecifiedPulmonary valve disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05843461
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05843461 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, Los Angeles and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.